anyone who bought this knew or should have known that arry had $90 mil in debt. This deal was done to pay it off. Read the offering prospectus.
I'm not happy about the price decline - but we exchanged the conv (and more shs) for less debt (err no debt now)
ARRY has many drugs in late stage trials. I'm happy to be long. I think a big pharma will come knocking on the door within a year at double the current price.